[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"hypertension-renovascular\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:hypertension-renovascular":25},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,41],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":40},"100268143","a-prospective-danish-national-registry-of-ptra-in-patients-with-renovascular-hypertension-100268143",false,"NCT02770066","A Prospective Danish National Registry of PTRA in Patients With Renovascular Hypertension","A Prospective Danish National Registry of Percutaneous Transluminal Renal Angioplasty in Patients With Renovascular Hypertension","DAN-PTRA","Eligibility criteria\n\n1. True resistant hypertension (≥ 3 antihypertensive drugs including a diuretic, if tolerated, and each prescribed at optimal doses) and uncontrolled blood pressure confirmed by 24-hour ambulatory blood pressure monitoring. The 24-hour ambulatory blood pressure monitoring is performed after nurse-administered medication and blood pressure measurements are performed hourly. If the average 24-hour ambulatory systolic blood pressure is ≥ 130 mmHg the patient can be evaluated for renal artery stenosis.\n2. Hypertension and intolerance or side effects of the antihypertensive treatment. Hypertension is confirmed by 24-hour ambulatory blood pressure monitoring. The 24-hour ambulatory blood pressure monitoring is performed after nurse-administered medication and blood pressure measurements are performed hourly. If the average 24-hour ambulatory systolic blood pressure is ≥ 130 mmHg the patient can be evaluated for renal artery stenosis.\n3. Progressive renal insufficiency (a reduction in eGFR \\> 5 ml\u002Fmin\u002F1,73 m2 per year) in patients with bilateral renal artery stenosis or in patients with renal artery stenosis and only one kidney.\n4. Recurrent heart failure\u002Fpulmonary edema and resistant hypertension (≥ 3 antihypertensive drugs including a diuretic, if tolerated, and each prescribed at optimal doses) that may not be attributed to non-compliance, reduced left heart ventricular ejection fraction\u002Fheart valve disease or other obvious explanations (atrial fibrillation, fever, hyperthyroidism etc.). If the average 24-hour ambulatory systolic blood pressure is ≥ 130 mmHg after nurse-administered medication the patient can be evaluated for renal artery stenosis.\n5. Younger patients (\\\u003C 40 years) with hypertension (24-hour ambulatory blood pressure monitoring ≥ 130\u002F80 mmHg after nurse-administered medication )\n\nInclusion Criteria:\n\nAll of the following:\n\n1. At least one of the above eligibility criteria\n2. Duplex doppler ultrasonography or renography investigations consistent with hemodynamically significant renal artery stenosis\n3. CT angiography or renal arteriography with angiographic renal artery stenosis of ≥ 70 % reduction of the luminal diameter in at least one projection\n\nExclusion Criteria:\n\n1. If angiography\u002Farteriography, ultrasonography or renography is consistent with bilateral significant renal artery stenosis and only one side is treated with PTRA\n2. PTRA of a renal artery supplying a kidney which pre-PTRA handles ≤ 10% of the total kidney function (with no blockage of the renin-angiotensin system) and has a kidney size \\\u003C 7 cm (length)","ALL",{"count":19,"type":20},160,"ESTIMATED","OBSERVATIONAL","A prospective Danish national registry of percutaneous transluminal renal angioplasty (PTRA) in high-risk patients with renal artery stenosis selected on the basis of common national criteria, and with a common follow-up protocol for all three Danish centres offering PTRA",[24,25,26,27],"Renal Artery Obstruction","Hypertension, Renovascular","Cardiovascular Diseases","Kidney Diseases","RECRUITING","2025-12-11",{"date":31,"type":32},"2025-12-18","ACTUAL",{"date":34,"type":4},"2015-01-01",{"date":36,"type":20},"2035-01",{"name":38,"class":39},"University of Aarhus","OTHER",5,{"id":42,"slug":43,"hasResults":11,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":4,"eligibilityCriteria":47,"healthyVolunteers":11,"sex":17,"minAge":48,"maxAge":49,"enrollmentInfo":50,"targetDuration":4,"studyType":52,"phases":53,"briefSummary":55,"conditions":56,"keywords":4,"overallStatus":57,"whyStopped":4,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":61,"completionDateStruct":63,"leadSponsor":65,"locationsCount":4},"100505195","drug-eluting-balloon-for-treatment-of-non-atherosclerotic-renal-artery-stenosis--a-multicenter-study-100505195","NCT05858190","Drug-eluting Balloon for Treatment of Non-atherosclerotic Renal Artery Stenosis--a Multicenter Study","Comparison of Drug Eluting Balloon and Plain Old Balloon for the Treatment of Non-atherosclerotic Renal Artery Stenosis--A Protocol of a Multicenter Study","Inclusion Criteria:\n\n* age between 18y and 45y.\n* with ≥ 60% stenosis in at least one renal artery.\n* with hypertension (systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥ 90 mmHg).\n* patients with no severe renal insufficiency (eGFR\\>30 ml\u002Fmin, length of the kidney ≥ 7cm).\n* Good compliance.\n* with informed consent.\n\nExclusion Criteria:\n\n* With apparent atherosclerotic risk factors.\n* With renal intervention or surgery history.\n* With congenital anatomical anomaly.\n* With severe renal insufficiency (length of the target kidney \\\u003C 7cm, total\n* eGFR\\\u003C30ml\u002Fmin, divided eGFR of the target kidney\\\u003C8 ml\u002Fmin)\n* With contraindication for antiplatelet therapy.\n* With severe cardiopulmonary insufficiency.\n* Allergic to contrast medium\n* Being pregnant or preparing for pregnancy\n* With active cancer.\n* Life expectancy \\\u003C 12 month\n* Without informed consent","18 Years","45 Years",{"count":51,"type":20},90,"INTERVENTIONAL",[54],"NA","The study will test the efficacy of drug eluting balloon(DEB) for non-atherosclerotic renal artery stenosis. The DEB (paclitaxel eluting balloon) will be used in the intervention group, while the plain old balloon(POB) will be used in the control group. The primary outcome is the effect of blood pressure control.",[25],"NOT_YET_RECRUITING","2023-05-04",{"date":60,"type":32},"2023-05-15",{"date":62,"type":20},"2023-06-01",{"date":64,"type":20},"2026-12-01",{"name":66,"class":39},"Peking Union Medical College Hospital"]